Literature DB >> 9885781

Long-lasting psychotomimetic consequences of repeated low-dose amphetamine exposure in rhesus monkeys.

S A Castner1, P S Goldman-Rakic.   

Abstract

The dopamine hypothesis of schizophrenia posits that dopamine dysregulation plays a key role in the etiology of schizophrenia. In line with this hypothesis, repeated amphetamine (AMPH) exposure has been shown to alter dopamine systems and induce behaviors reminiscent of positive-like and negative-like symptoms in both human and nonhuman primates. The mechanisms by which AMPH produces disturbances in brain function and behavior are not fully understood. The present study has employed a novel AMPH regimen, 12 weeks of intermittent escalating low doses of AMPH, to produce a nonhuman primate model for the purpose of elucidating the behavioral and neural consequences of excessive dopamine exposure. Behavioral responses to acute AMPH challenge (0.4-0.46 mg/kg) were assessed prior to and following the chronic 12-week treatment regimen, and, at present monkeys have been followed out to 28 months post-treatment. After chronic treatment, enhanced behavioral responses to AMPH challenge were readily apparent at 5 days postwithdrawal, and, were still present at 28 months postwithdrawal. The enhanced behavioral responses to low-dose AMPH challenge that were observed in the present study resemble closely the behavioral profile that has been described for chronic high-dose AMPH treatment in monkeys; i.e., hallucinatory-like behaviors, static posturing, and fine-motor stereotypies were all exacerbated in response to AMPH injection. In some animals, acute challenges after chronic AMPH evoked aberrant behavioral responses that lasted for 4 days. AMPH-treated monkeys also exhibited a significant decrease in the incidence of motor stereotypies in the off-drug periods between challenges. The present results are the first to document persistent long-term behavioral effects of intermittent exposure to repeated low-dose AMPH treatment in nonhuman primates. These findings may lay the groundwork for the development of a primate mode of psychosis with possible positive-like and negative-like symptoms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9885781     DOI: 10.1016/S0893-133X(98)00050-5

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  35 in total

1.  Acute and chronic dopamine dynamics in a nonhuman primate model of recreational cocaine use.

Authors:  C W Bradberry
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

2.  Repeated maternal separation: differences in cocaine-induced behavioral sensitization in adult male and female mice.

Authors:  Takefumi Kikusui; Sara Faccidomo; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2004-08-21       Impact factor: 4.530

3.  Repetitive behaviors in monkeys are linked to specific striatal activation patterns.

Authors:  Esen Saka; Claudia Goodrich; Patricia Harlan; Bertha K Madras; Ann M Graybiel
Journal:  J Neurosci       Date:  2004-08-25       Impact factor: 6.167

4.  Amphetamine withdrawal alters bistable states and cellular coupling in rat prefrontal cortex and nucleus accumbens neurons recorded in vivo.

Authors:  S P Onn; A A Grace
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

Review 5.  Divergent plasticity of prefrontal cortex networks.

Authors:  Bita Moghaddam; Houman Homayoun
Journal:  Neuropsychopharmacology       Date:  2007-10-03       Impact factor: 7.853

Review 6.  Review. Psychological and neural mechanisms of relapse.

Authors:  Jane Stewart
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-10-12       Impact factor: 6.237

7.  On the neurobiology of hallucinations.

Authors:  Patricia Boksa
Journal:  J Psychiatry Neurosci       Date:  2009-07       Impact factor: 6.186

8.  The discriminative effects of the kappa-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects.

Authors:  Eduardo R Butelman; Szymon Rus; Thomas E Prisinzano; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2010-01-19       Impact factor: 4.530

Review 9.  Cued for risk: Evidence for an incentive sensitization framework to explain the interplay between stress and anxiety, substance abuse, and reward uncertainty in disordered gambling behavior.

Authors:  Samantha N Hellberg; Trinity I Russell; Mike J F Robinson
Journal:  Cogn Affect Behav Neurosci       Date:  2019-06       Impact factor: 3.282

Review 10.  From drugs to deprivation: a Bayesian framework for understanding models of psychosis.

Authors:  P R Corlett; C D Frith; P C Fletcher
Journal:  Psychopharmacology (Berl)       Date:  2009-05-28       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.